Atlas Trials

A Clinical Trial of TQB6426 for Injection in Patients With Advanced Solid Tumors

Clinical trial NCT07730190 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07730190
Sponsor
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Malignancies
Start date
2026-08-01
Primary completion
2027-08-01
Enrollment
151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.